Elsevier

Neuropharmacology

Volume 71, August 2013, Pages 273-281
Neuropharmacology

Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca2+ dependent manner

https://doi.org/10.1016/j.neuropharm.2013.04.010Get rights and content

Highlights

  • Coactivation of dopamine D3 receptors with D1 receptors potentiates cAMP formation and GABA release in SNr.

  • The potentiating effects of activating dopamine D3 receptors are antagonized by procedures that increase cytoplasmic Ca2+.

  • The effects of increasing cytoplasmic Ca2+ are reversed by CAMKII antagonist KN-62.

  • Dopamine D3 receptor activity is inhibited by binding to CAMKII.

Abstract

CaMKIIα is expressed at high density in the nucleus accumbens where it binds to postsynaptic D3 receptors inhibiting their effects. In striatonigral projections, activation of presynaptic D3 receptors potentiates D1 receptor-induced stimulation of cAMP production and GABA release. In this study we examined whether the presynaptic effects of D3 receptor stimulation in the substantia nigra reticulata (SNr) are modulated by Ca2+ activation of CaMKIIα. In SNr synaptosomes two procedures that increase cytoplasmic Ca2+, ionomycin and K+-depolarization, blocked the additional stimulation of cAMP accumulation produced by coactivating D3 and D1 dopamine receptors. The selective CaMKIIα inhibitor KN-62 reversed the blockade produced by ionomycin and K+-depolarization. Incubation in either Ca2 -free solutions or with the selective Ca2+ blocker nifedipine, also reversed the blocking effects of K+-depolarization. Immunoblot studies showed that K+-depolarization increased CaMKIIα phosphorylation in a KN-62 sensitive manner and promoted CaMKIIα binding to D3 receptors. In K+-depolarized tissues, D3 receptors potentiated D1 receptor-induced stimulation of [3H]GABA release only when CaMKIIα was blocked with KN-62. In the presence of this inhibitor, the selective D3 agonist PD 128,907 reduced the ED50 for the D1 agonist SKF 38393 from 56 to 4 nM. KN-62 also enhanced the effects of dopamine on depolarization induced [3H]GABA release. KN-62 changed ED50 for dopamine from 584 to 56 nM. KN-62 did not affect D1 and D4 receptor responses. These experiments show that in striatonigral projections, CaMKIIα inhibits the action of D3 receptors in a Ca2+ dependent manner blocking their modulatory effects on GABA release. These findings suggest a mechanism through which the frequency of action potential discharge in presynaptic terminals regulates dopamine effects.

Introduction

Dopamine modifies neuronal function by interacting with two classes of G protein-coupled receptor families, the D1 family (that includes D1 and D5 receptors) typically coupled to Gs proteins and the D2 family (D2, D3, and D4 receptors) typically couple to Gi proteins (Neve et al., 2004). The rat D3 receptor (D3R) messenger translates a 446 amino acid protein that has 52% homology with the rat D2 receptor; 75% of the homology is in the transmembrane-spanning domains. D3Rs are preferentially expressed in the mesolimbic dopaminergic projection areas, including the nucleus accumbens (NAc) (Sokoloff et al., 1990; Bouthenet et al., 1991). In the nucleus accumbens D3Rs behave as typical D2 family receptors, i.e., they are coupled with Gi proteins inhibiting adenylyl cyclase (Schwartz et al., 1998). Recently it has been shown that D3R function in the NAc is markedly regulated by Ca2+/calmodulin-dependent protein kinase II α (CaMKIIα). In this structure CaMKIIα binds to D3Rs in a Ca2+-sensitive manner, phosphorylating the receptor and inhibiting its function (Liu et al., 2009).

D3Rs are also active in striatonigral nerve endings where they modulate GABA release (Cruz-Trujillo et al., 2013). In these structures the D3R signaling pathway is “atypical”. Instead of acting through coupling to Gi proteins; D3Rs enhance D1R-stimulated cAMP production and GABA release (Cruz-Trujillo et al., 2013). Since CaMKIIα is an abundant enzyme in the brain, especially at synaptic sites (Kelly et al., 1984), we examined whether it also modulates D3Rs signaling localized in presynaptic endings where it is mediated by an “atypical” pathway.

CaMKIIα activity depends on the level of cytoplasmic Ca2+ (Lisman et al., 2002). As cytoplasmic Ca2+ increases, the enzyme is removed from its autoinhibitory state and becomes activated by the binding of Ca2+ and calmodulin (CaM). Activated CaMKIIα phosphorylates its substrates as well as an autophosphorylation site within its autoregulatory domain. The autophosphorylation results in a Ca2+/CaM-independent kinase activity even after the initial Ca2+ stimulus subsides (Hudmon and Schulman, 2002; Colbran and Brown, 2004; Griffith, 2004).

In this study we evaluated whether procedures that markedly enhance cytoplasmic Ca2+ modify the effects of activating D3Rs in the striatal projections to the SNr via a CaMKIIα-mediated process. We concentrated, mostly, on the effects of K+-induced depolarization because this procedure triggers Ca2+-dependent transmitter release that is akin to the naturally occurring process (Bernath, 1992). Furthermore, K+ depolarization of neuronal cultures leads to CaMKIIα accumulation near active zones (AZs) (Tao-Cheng et al., 2006).

Regulation of dopaminergic receptors at presynaptic endings by CaMKIIα is very likely of functional relevance since neural activity modifies presynaptic CaMKIIα activity (see Shakiryanova et al., 2011). An account of our results has already been published in preliminary form (Arturo et al., 2010).

Section snippets

Animals

Male Wistar rats (180–200 g) housed together (five per cage) with water and food available ad libitum and kept under a natural light cycle were used throughout. All the procedures were carried out in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals and were approved by the Institutional Animal Care Committee of the CINVESTAV.

Depletion of endogenous dopamine by reserpine

As indicated in the legends in most experiments rats were pretreated with reserpine (10 mg kg−1, i.p.) 18 h before preparation

Increased cytoplasmic Ca2+ inhibits the potentiating effects of D3 receptor activation on D1 mediated cAMP production

Coactivation of D1Rs and D3Rs stimulate cAMP production and GABA release in SNr (Cruz-Trujillo et al., 2013) .The effects of two treatments, ionomycin and K+-depolarization, that increase cytoplasmic Ca2+ in synaptosomes (Nachshen, 1985; Verhage et al., 1988, 1989) on the cAMP response are illustrated in Fig. 1A and B. D1R stimulation with the selective agonist SKF 38393 (1 μM) increased cAMP production (to 126.3 ± 0.3% in Fig. 1A and to 125.7 ± 1.20% in Fig. 1B, over the control; p < 0.001 for

CaMKIIα modulates D3R receptor function in striatonigral terminals

These experiments establish that CaMKIIα modulates D3R function in the SNr. In this structure D3R activation potentiates the stimulation of GABA release and cAMP accumulation produced by stimulation of D1Rs (Cruz-Trujillo et al., 2013). Two procedures, ionomycin and K+ depolarization, that increase cytoplasmic [Ca2+] blocked D3R mediated stimulation of adenylyl cyclase. The selective CAMKIIα inhibitor KN-62 reversed these blocking effects indicating that CaMKIIα activation mediates this

Acknowledgments

The work was supported by a grant (152326) from CONACyT (México) to BF. We thank Dr. Mimi Halpern for correcting our manuscript.

References (55)

  • I. Grofova

    The identification of striatal and pallidal neurons projecting to substantia nigra. An experimental study by means of retrograde axonal transport of horseradish peroxidase

    Brain Res.

    (1975)
  • C.C. Huang et al.

    Activation of NMDA receptors reduces metabotropic glutamate receptor-induced long-term depression in the nucleus accumbens via a CaMKII-dependent mechanism

    Neuropharmacology

    (2012)
  • M. Kubota et al.

    Type-3 ryanodine receptor involved in Ca2+-induced Ca2+ release and transmitter exocytosis at frog motor nerve terminals

    Cell Calcium

    (2005)
  • X.Y. Liu et al.

    Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII

    Neuron

    (2009)
  • D. Marcellino et al.

    Identification of dopamine D1–D3 receptor heteromers. Indications for a role of synergistic D1–D3 receptor interactions in the striatum

    J. Biol. Chem.

    (2008)
  • M.A. Merrill et al.

    Activity-driven postsynaptic translocation of CaMKII

    Trends Pharmacol. Sci.

    (2005)
  • C. Nava-Asbell et al.

    GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata

    Neuropharmacology

    (2007)
  • T. Onda et al.

    Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms

    J. Biol. Chem.

    (2001)
  • C. Rangel-Barajas et al.

    6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat

    Neuropharmacology

    (2008)
  • C. Rangel-Barajas et al.

    L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

    Neurobiol. Dis.

    (2011)
  • C.E. Ribak et al.

    GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways

    Brain Res.

    (1980)
  • J.C. Schwartz et al.

    Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence

    Brain Res. Brain Res. Rev.

    (1998)
  • S. Strack et al.

    Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase II to the postsynaptic density

    J. Biol. Chem.

    (1997)
  • H. Tokumitsu et al.

    KN-62, 1-[N, O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II

    J. Biol. Chem.

    (1990)
  • M. Wassef et al.

    Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration

    Neuroscience

    (1981)
  • J. Aceves et al.

    Dopaminergic presynaptic modulation of nigral afferents: its role in the generation of recurrent bursting in substantia nigra pars reticulata neurons

    Front. Syst. Neurosci.

    (2011)
  • S.P. Alexander

    The measurement of cyclic AMP levels in biological preparations

    Methods Mol. Biol.

    (1995)
  • Cited by (19)

    • Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

      2020, Ageing Research Reviews
      Citation Excerpt :

      It was proved that the interaction of D3R on D1R increases the affinity of D1R with its ligand, but has little effect on the affinity of D3R with its ligand (Marcellino et al., 2008). For example, selective D3R agonist PD128907 reduced the ED50 for the D1R agonist SKF 38393 from 56 to 4 nM in certain circumstances (Avalos-Fuentes et al., 2013). Once the affinity of DA to D1R is increased, G-protein signaling and cAMP accumulation is enhanced (Leggio et al., 2016).

    • Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca<sup>2+</sup> dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat

      2015, Neurobiology of Disease
      Citation Excerpt :

      Similar synergistic effects have also been detected on other signaling cascades in experiments using neural tissues and heterologous expression systems (Fiorentini et al, 2008, Marcellino et al., 2008, Schwartz et al., 1998, Guitart et al., 2014). Our evidence of synergistic D3/D1 interactions in striatonigral terminals was obtained using three independent techniques (electrophysiological determinations, Cruz-Trujillo et al, 2013; cAMP production, Cruz-Trujillo et al., 2013; Avalos-Fuentes et al., 2013; and GABA release, Avalos-Fuentes et al., 2013). Control of GABA release by cytoplasmic cAMP is proposed on the basis of prior findings in the literature (Capogna et al., 1995, Wang and Johnson, 1995; Kondo and Marty, 1997; Shindou et al., 2002, Nava-Asbell et al., 2007).

    View all citing articles on Scopus
    View full text